Systemic Adverse Effects Induced by the BNT162b2 Vaccine Are Associated with Higher Antibody Titers from 3 to 6 Months after Vaccination.
Ryousuke KoikeMichiru SawahataYoshikazu NakamuraYushi NomuraOtohiro KatsubeKoichi HagiwaraSeiji NihoNorihiro MasudaTakaaki TanakaKumiya SugiyamaPublished in: Vaccines (2022)
Participants with systemic adverse effects tend to have higher Ab titers from 3 to 6 months after the second dose of the BNT162b2 vaccine. Our results may encourage vaccination, even among people with vaccine hesitancy related to relatively common systemic adverse effects.
Keyphrases